Brief: Pharmasimple: Approval Of Capital Increase Up To A Maximum Of €300 Mln
Feb 7 (Reuters) - Pharmasimple SA ALPHS.PA :
* PHARMASIMPLE SAID ON FRIDAY THAT THE EXTRAORDINARY
SHAREHOLDERS'
MEETING APPROVES THE RESOLUTIONS NECESSARY TO IMPLEMENT THE
TRANSFORMATION PLAN BY A LARGE MAJORITY
* APPROVED TO INCREASE THE SHARE CAPITAL UP TO A MAXIMUM
AMOUNT OF
300 MILLION EUROS (INCLUDING ISSUE PREMIUM)
Source text for Eikon: ID:nACT73117
Further company coverage: ALPHS.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Pharmasimple SA
See all newsBrief: Pharmasimple Says It Received Order To Suspend Stock Consolidation
Brief: Pharmasimple Says Stock Consolidation Approved
Brief: Pharmasimple H1 EBITDA Loss Widens To 3.6 Million Euros
Brief: Pharmasimple Announces Reverse Stock Split
Brief: Pharmasimple: Suspension Of OCA Drawdowns From Oct For At Least 6 Months